This is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units
This new facility integrates multi-channel chip, micro-mixer system, and complex preparation system into a multi-channel micro-mixer core LNP manufacturing platform
This biopharmaceutical facility is one most significant private sector investment ever in the Middletown region
WuXi STA opens a new large scale continuous manufacturing plant
Better serving global partners and advancing healthcare innovation
AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing
Site Enhances New Modality CRDMO Platform Capacity for Customers
WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
UK Prime Minister Keir Starmer praised the initiative, saying: “Unlocking opportunities for British businesses across the globe and delivering for working people back home is always the driving force behind my international engagements."
Subscribe To Our Newsletter & Stay Updated
